Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Pediatrix Medical (MD) Shares Outstanding (Diluted Average): 2009-2020

Historic Shares Outstanding (Diluted Average) for Pediatrix Medical (MD) over the last 6 years, with FY2020 value amounting to $85.1 million.

  • Pediatrix Medical's Shares Outstanding (Diluted Average) rose 325.12% to $85.5 million in Q1 2021 from the same period last year, while for Mar 2021 it was $85.5 million, marking a year-over-year increase of 325.12%. This contributed to the annual value of $85.1 million for FY2020, which is 127.48% up from last year.
  • According to the latest figures from FY2020, Pediatrix Medical's Shares Outstanding (Diluted Average) is $85.1 million, which was up 127.48% from $84.0 million recorded in FY2019.
  • Pediatrix Medical's Shares Outstanding (Diluted Average)'s 5-year high stood at $93.0 million during FY2017, with a 5-year trough of $84.0 million in FY2019.
  • In the last 4 years, Pediatrix Medical's Shares Outstanding (Diluted Average) had a median value of $88.3 million in 2018 and averaged $88.4 million.
  • As far as peak fluctuations go, Pediatrix Medical's Shares Outstanding (Diluted Average) crashed by 829.09% in 2019, and later soared by 127.48% in 2020.
  • Pediatrix Medical's Shares Outstanding (Diluted Average) (Annual) stood at $93.0 million in 2017, then dropped by 1.45% to $91.6 million in 2018, then decreased by 8.29% to $84.0 million in 2019, then grew by 1.27% to $85.1 million in 2020.
  • Its Shares Outstanding (Diluted Average) was $85.1 million in FY2020, compared to $84.0 million in FY2019 and $91.6 million in FY2018.